Evidence map›Paper›PMID 26488883›Full record

ArticlePloS one2015

Dermatan Sulfate-Free Mice Display Embryological Defects and Are Neonatal Lethal Despite Normal Lymphoid and Non-Lymphoid Organogenesis.

Xanthi N Stachtea, Emil Tykesson, Toin H van Kuppevelt, Ricardo Feinstein, Anders Malmström, Rogier M Reijmers, Marco Maccarana

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Quantification of chondroitin sulfate, hyaluronic acid andOsteoarthritis and cartilage open · 2023
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. An Overview ofFrontiers in cell and developmental biology · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Dermatan sulfate epimerase 1 and dermatan 4-The Journal of biological chemistry · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Xanthi N StachteaDepartment of Experimental Medical Science, Lund University, Lund, Sweden.
Emil TykessonDepartment of Experimental Medical Science, Lund University, Lund, Sweden.
Toin H van KuppeveltDepartment of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Ricardo FeinsteinDepartment of Pathology, The National Veterinary Institute (SVA), SE 75189, Uppsala, Sweden.
Anders MalmströmDepartment of Experimental Medical Science, Lund University, Lund, Sweden.
Rogier M ReijmersDepartment of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, the Netherlands.
Marco MaccaranaDepartment of Experimental Medical Science, Lund University, Lund, Sweden.
Lund University · SEAmsterdam UMC Location VUmc · NLRadboud University Medical Center · NLSwedish Veterinary Agency · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epimerization of glucuronic acid into iduronic acid adds structural variability to chondroitin/dermatan sulfate polysaccharides. Iduronic acid-containing domains play essential roles in processes such as coagulation, chemokine and morphogen modulation, collagen maturation, and neurite sprouting. Therefore, we generated and characterized, for the first time, mice deficient in dermatan sulfate epimerase 1 and 2, two enzymes uniquely involved in dermatan sulfate biosynthesis. The resulting mice, termed DKO mice, were completely devoid of iduronic acid, and the resulting chondroitin sulfate chains were structurally different from the wild type chains, from which a different protein binding specificity can be expected. As a consequence, a vast majority of the DKO mice died perinatally, with greatly variable phenotypes at birth or late embryological stages such as umbilical hernia, exencephaly and a kinked tail. However, a minority of embryos were histologically unaffected, with apparently normal lung and bone/cartilage features. Interestingly, the binding of the chemokine CXCL13, an important modulator of lymphoid organogenesis, to mouse DKO embryonic fibroblasts was impaired. Nevertheless, the development of the secondary lymphoid organs, including the lymph nodes and spleen, was normal. Altogether, our results indicate an important role of dermatan sulfate in embryological development and perinatal survival.

Indexed as

OrganogenesisAnimalsAnimals, NewbornBlotting, WesternCarbohydrate EpimerasesCells, CulturedChemokine CXCL13Chondroitin SulfatesDermatan SulfateDisaccharidesEmbryo, MammalianFibroblastsLymphoid TissueMice, 129 StrainMice, Inbred C57BLMice, KnockoutCarbohydrate EpimerasesChemokine CXCL13Chondroitin SulfatesDermatan Sulfatedermatan sulfate epimerase 1, mouseDisaccharides

Identifiers

PMID26488883
PMCPMC4619018
OpenAlexW2151003482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.